NCT03621813

Brief Summary

Exercise rehabilitation has the potential as a non-pharmacological approach to reduce persistent neuropathic pain in Veterans with lung cancer. By examining the effects of exercise training in Veteran cancer survivors with NSCLC, there is the potential to revolutionize care for a: common, debilitating, and inadequately treated symptom in a growing population. This could lead to a larger investigation to fill critical gaps in the literature and at the same time help discover a new model of care for Veterans with chronic pain. The ultimate goal is to reduce this type of pain for the growing population of cancer survivors while simultaneously reducing the need for problematic opioid management.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for not_applicable cancer

Timeline
8mo left

Started Aug 2019

Longer than P75 for not_applicable cancer

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Aug 2019Dec 2026

First Submitted

Initial submission to the registry

August 3, 2018

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 8, 2018

Completed
1 year until next milestone

Study Start

First participant enrolled

August 19, 2019

Completed
7.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2026

Expected
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Last Updated

February 18, 2026

Status Verified

February 1, 2026

Enrollment Period

7.3 years

First QC Date

August 3, 2018

Last Update Submit

February 13, 2026

Conditions

Keywords

Neuropathic PainExerciseLung Cancer

Outcome Measures

Primary Outcomes (1)

  • Pain Visual Analog Scale Change

    Scale of 0 (no pain) to 100 (worst imaginable pain)

    Measured at baseline, after 6 weeks control, and after 6 week intervention

Secondary Outcomes (3)

  • Patient-Reported Outcomes Measurement System Neuropathic Pain Quality (PROMIS-PQ Neuro) Change

    Measured at baseline, after 6 weeks control, and after 6 week intervention

  • Fitness Change

    Measured at baseline, after 6 weeks control, and after 6 week intervention

  • Strength Change

    Measured at baseline, after 6 weeks control, and after 6 week intervention

Study Arms (2)

Control

OTHER

Participants maintain their current activity level.

Other: Control

Exercise Rehabilitation

ACTIVE COMPARATOR

Participants will exercise 2x/week at training facilities and at home one day a week.

Behavioral: Exercise Rehabilitation

Interventions

This training is designed to improve fitness, target the major muscle groups for strength, and to improve balance. Aerobic exercise of walking on a treadmill will be performed. Thera-Bands will be used for resistance exercise for the lower and upper body. Balance program includes core exercises (stepping, weight shifts, etc.) and other progressive exercises.

Exercise Rehabilitation
ControlOTHER

Participants are instructed to maintain current activity level and are monitored for changes.

Control

Eligibility Criteria

Age60 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 60-80 years
  • Diagnosis with lung cancer
  • History of treatment with either thoracotomy procedure or neurotoxic chemotherapy or both
  • Completion of thoracotomy or chemotherapy \> or = 6 months
  • Ability to walk on a treadmill
  • Karnofsky performance status \> 70
  • Score \> 1 Neuropathic Pain Scale

You may not qualify if:

  • Presence of metastatic (stage IV)
  • Life expectancy \< 6 months
  • Musculoskeletal or medical conditions which preclude participation in an exercise program

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

Baltimore, Maryland, 21201, United States

Location

MeSH Terms

Conditions

NeoplasmsNeuralgiaMotor ActivityLung Neoplasms

Interventions

Exercise Therapy

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBehaviorRespiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy Modalities

Study Officials

  • Alice S. Ryan, PhD

    Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Model Details: Cancer survivors will be enrolled in a 6-week delayed entry control period followed by 6-week exercise rehabilitation program.
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 3, 2018

First Posted

August 8, 2018

Study Start

August 19, 2019

Primary Completion (Estimated)

December 20, 2026

Study Completion (Estimated)

December 30, 2026

Last Updated

February 18, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations